Lingyun Ma

530 total citations
39 papers, 362 citations indexed

About

Lingyun Ma is a scholar working on Epidemiology, Pharmacology and Neurology. According to data from OpenAlex, Lingyun Ma has authored 39 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Pharmacology and 6 papers in Neurology. Recurrent topics in Lingyun Ma's work include Multiple Sclerosis Research Studies (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Lingyun Ma is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Lingyun Ma collaborates with scholars based in China, United Kingdom and United States. Lingyun Ma's co-authors include Yimin Cui, Ying Zhou, Chaoyang Chen, Xiaodan Wang, Zhichao Chen, Shuai Liu, Xin Tian, Peng Xiao, Min Li and Yong Ji and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Chemistry.

In The Last Decade

Lingyun Ma

36 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingyun Ma China 11 63 61 59 49 48 39 362
Mustafa Büyükavcı Türkiye 13 82 1.3× 19 0.3× 38 0.6× 18 0.4× 38 0.8× 53 526
Rónan Astin United Kingdom 9 72 1.1× 40 0.7× 137 2.3× 9 0.2× 32 0.7× 17 407
Jelena P. Seferović Serbia 12 86 1.4× 23 0.4× 55 0.9× 24 0.5× 22 0.5× 26 672
Wanli Zhang China 14 49 0.8× 23 0.4× 66 1.1× 20 0.4× 39 0.8× 45 541
Thiago Ruiz Rodrigues Prestes Brazil 6 70 1.1× 115 1.9× 65 1.1× 28 0.6× 11 0.2× 7 333
S. Bergmann Germany 13 88 1.4× 14 0.2× 85 1.4× 31 0.6× 23 0.5× 36 622
Ivan Cancarevic United States 14 112 1.8× 14 0.2× 22 0.4× 43 0.9× 34 0.7× 47 524
Wanxia Yao China 11 86 1.4× 54 0.9× 34 0.6× 21 0.4× 9 0.2× 19 405
Rafik Tadros Canada 19 345 5.5× 64 1.0× 36 0.6× 17 0.3× 18 0.4× 74 1.2k
Christine De Staercke United States 14 131 2.1× 13 0.2× 36 0.6× 12 0.2× 18 0.4× 24 465

Countries citing papers authored by Lingyun Ma

Since Specialization
Citations

This map shows the geographic impact of Lingyun Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyun Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyun Ma more than expected).

Fields of papers citing papers by Lingyun Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingyun Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyun Ma. The network helps show where Lingyun Ma may publish in the future.

Co-authorship network of co-authors of Lingyun Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Lingyun Ma. A scholar is included among the top collaborators of Lingyun Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyun Ma. Lingyun Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yan, Pengfei Li, Qiang Ma, et al.. (2025). Antondine Injection-Associated Fixed Drug Eruption: A Case Report. Clinical Medicine Insights Case Reports. 18.
2.
Fu, Rongguo, et al.. (2024). The designing of a far-field laser facula measurement system based on detector array. 5. 74–74. 1 indexed citations
3.
Ma, Lingyun, et al.. (2024). Investigating the neuroprotective potential of rAAV2‐PCBP1‐EGFP gene therapy against a 6‐OHDA‐induced model of Parkinson's disease. Brain and Behavior. 14(1). e3376–e3376. 1 indexed citations
4.
Yang, Xia, et al.. (2024). Association between Body Mass Index or Serum Albumin and Different Dementia Populations. European Neurology. 87(4). 159–168.
5.
Huang, Hanhan, Wenjing Zhang, Lingyun Ma, et al.. (2024). Structure based release kinetics analysis of doxazosin mesylate sustained-release tablets using micro-computed tomography. Asian Journal of Pharmaceutical Sciences. 19(6). 100966–100966.
6.
Liu, Botao, Lingyun Ma, Jing Xu, & Gege Yan. (2023). CAR-T therapy for breast cancer. Theoretical and Natural Science. 20(1). 178–186. 1 indexed citations
7.
Ma, Lingyun, Fangfang He, Shuai Liu, et al.. (2022). The Association Between the Prevalence, Medication Adherence and Control of Hypertension and the Prevalence of Mild Cognitive Impairment in Rural Northern China: A Cross-Sectional Study. SHILAP Revista de lepidopterología. 10 indexed citations
8.
Ma, Jun, et al.. (2022). Association of Homocysteine Levels With Medial Temporal Lobe Atrophy Among Carriers and Non-carriers of APOE ε4 in MCI Subjects. Frontiers in Psychiatry. 13. 823605–823605. 4 indexed citations
9.
Chen, Zhichao, et al.. (2021). Orexin-A in Patients With Lewy Body Disease: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology. 12. 765701–765701. 6 indexed citations
10.
Zhang, Guili, Shuai Liu, Zhichao Chen, et al.. (2021). Association of Elevated Plasma Total Homocysteine With Dementia With Lewy Bodies: A Case-Control Study. Frontiers in Aging Neuroscience. 13. 724990–724990. 6 indexed citations
11.
Zhang, Enyao, Xin Tian, Ruoming Li, et al.. (2021). Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials. Orphanet Journal of Rare Diseases. 16(1). 87–87. 21 indexed citations
12.
Ma, Lingyun, Xiaodan Wang, Shuai Liu, et al.. (2021). Prevalence and risk factors of stroke in a rural area of northern China: a 10-year comparative study. Aging Clinical and Experimental Research. 34(5). 1055–1063. 4 indexed citations
13.
Liu, Shuai, Fei Wang, Han Zhu, et al.. (2021). Autonomic symptoms are predictive of dementia with Lewy bodies. Parkinsonism & Related Disorders. 95. 1–4. 10 indexed citations
14.
Ma, Lingyun, Ting Yang, Songtao Wu, et al.. (2020). Combined therapy of somatostatin analogues with pegvisomant for the treatment of acromegaly: a meta-analysis of prospective studies. BMC Endocrine Disorders. 20(1). 126–126. 11 indexed citations
15.
Tian, Xin, Lingyun Ma, Ran Wei, et al.. (2020). Efficacy and safety of rituximab in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis. Journal of Neuroimmunology. 347. 577317–577317. 10 indexed citations
16.
Wei, Ran, Xin Tian, Chaoyang Chen, et al.. (2020). Efficacy and safety of azathioprine for neuromyelitis optica spectrum disorders: A meta-analysis of real-world studies. Multiple Sclerosis and Related Disorders. 46. 102484–102484. 10 indexed citations
17.
Yang, Ting, Min Li, Chaoyang Chen, et al.. (2019). Efficacy and safety of sapropterin dihydrochloride in patients with phenylketonuria: A meta‐analysis of randomized controlled trials. British Journal of Clinical Pharmacology. 85(5). 893–899. 17 indexed citations
18.
Zhou, Ying, Chaoyang Chen, Lingyun Ma, et al.. (2018). Development of a Population Pharmacokinetic Model of Vancomycin and its Application in Chinese Geriatric Patients with Pulmonary Infections. European Journal of Drug Metabolism and Pharmacokinetics. 44(3). 361–370. 18 indexed citations
19.
Ma, Lingyun, Qian Xiang, Xueying Li, et al.. (2017). Vancomycin-associated acute kidney injury: A cross-sectional study from a single center in China. PLoS ONE. 12(4). e0175688–e0175688. 34 indexed citations
20.
Ma, Lingyun. (2011). Investigation of chemical volatile compounds of south bay bighead carp by GC/MS. Food and Machinery. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026